GlassScriptPhysician profile
Robin L Houpe
NPI 1285843607
$572.85
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $72.46 · 2021: $20.37 · 2022: $14.51 · 2023: $111 · 2024: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.99 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $126.29 | 2023-2024 | Veozah |
| Allergan, INC. | $80.76 | 2019-2020 | |
| Abbvie INC. | $57.18 | 2020-2023 | |
| Hologic Sales and Service, LLC | $51.66 | 2020-2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $48.18 | 2019-2020 | |
| Coopersurgical, INC. | $45.66 | 2019-2020 | |
| Evofem Biosciences, INC. | $37.20 | 2021-2023 | Phexxi |
| Exeltis, USA INC. | $27.47 | 2023 | Slynd |
| Ethicon US, LLC | $26.87 | 2019 | |
| Duchesnay USA Incorporated | $17.59 | 2019 | |
| Roche Diagnostics Corporation | $16.41 | 2019 | |
| Therapeuticsmd, INC. | $16.12 | 2019 | |
| Biogen, INC. | $15.66 | 2024 | |
| Mayne Pharma Commercial LLC | $5.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Houpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.